Publication | Closed Access
Affinity in Radioimmunoassay of Antibody Cross-Reactive with Carcinoembryonic Antigen (CEA) and Colon Carcinoma Antigen-III (CCA-III)
29
Citations
0
References
1977
Year
Colon Carcinoma Antigen-iiiImmunologyImmune RegulationPathologyImmunoeditingImmunotherapeuticsImmunotherapyTumor ImmunologyOncologyTumor ImmunityColon CarcinomaImmunochemistryAntibody EngineeringCarcinoembryonic AntigenRadiation OncologyCancer ResearchAbstract Several AntiseraColorectal CancerImmune SurveillanceCommon Site AntibodyCancer ImmunosurveillanceMedicine
Abstract Several antisera raised against purified carcinoembryonic antigen (CEA) were evaluated for their content of antibody cross-reactive with colon carcinoma antigen-III (CCA-III). All antisera gave a reaction of partial identity between CEA and CCA-III and demonstrated a high titer in CEA radioimmunoassay (RIA). Between 50 and 70% of the CEA RIA activity was removed, however, by absorption with soluble CCA-III or adsorption onto CCA-III-containing immunoadsorbents. Immunoadsorbent retained antibody gave a line of complete identity between CEA and CCA-III. Purified CCA-III (2 µg) only partially depressed CEA binding by this common site antibody, whereas nanogram quantities of CCA-III inhibited the reaction between specific CCA-III antibody and radioiodinated CCA-III. In addition, low levels of CEA were equally effective in depressing CEA binding by the common site or CEA-specific antibody. The higher affinity in RIA of the common site antibody for CEA over CCA-III suggests that the common determinant expressed on CEA is stereochemically different from that on CCA-III. The results further demonstrate that interference by plasma CCA-III is not a significant factor in the measurement of CEA by RIA.